Michael Biega
Vice President of Investor Relations & Communications
All right. We can get started. Good morning, everyone. Welcome to Harrow’s Inaugural Investor and Analyst Day. My name is Mike Biega. I am the Vice President of Investor Relations and Communications, and we’re thrilled to be here with all of you today. The company’s remarks may include forward-looking statements within the meaning of federal securities law.
Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond Harrow’s control, including risks and uncertainties described from time to time in its SEC filings, such as the risks and uncertainties related to the company’s ability to make commercially available, its FDA-approved products, in compounded formulations and technologies, and FDA approval of certain drug candidates in a timely manner or at all.
For a list and description of those risks and uncertainties, please see the Risk Factors section of the company’s most recent annual report on Form 10-K and subsequent quarterly earnings reports on Form 10-Q, filed with the Securities and Exchange Commission. We have a very full agenda plan for today.
We’ll start with about 2.5 to 3 hours of prepared remarks, followed by roughly 30 minutes of questions. I do kindly ask that you hold all of your questions until after the presentations and then when we reach this Q&A session, raise your hand, I’ll come around
Credit: Source link
